ArticleCancer immunology, immunotherapy : CII2025

Clofazimine enhances anti-PD-1 immunotherapy in glioblastoma by inhibiting Wnt6 signaling and modulating the tumor immune microenvironment.

Yuze Zhao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.